FDA.reportPublic FDA data

Bupropion Hydrochloride

Product NDC
82009-051
11-digit product format
820090051
Labeler code
82009
Product ID
82009-051_83a2b271-e681-44ec-83b2-c9e596e7ee05
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Bupropion Hydrochloride
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Quallent Pharmaceuticals Health LLC
Application
ANDA090693
Marketing category
ANDA
Marketing start
2023-07-07
Substance
BUPROPION HYDROCHLORIDE
Active strength
150 mg/1
Pharmacologic classes
Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Bupropion Hydrochloride
Brand name suffix
XL
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BUPROPION HYDROCHLORIDE150 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiZG7E5POY8O
Rxcui993541, 993557

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4eceb285-f3c7-4092-a21a-4c9f3169f20cProduct name520260220
548ba7fd-fd0c-4a21-b2b0-d01bf93143b8Product name320240209
43a1ed49-eae2-4840-8075-cb4b33478540Product name120230425
b8ee525f-67fb-39fb-91da-7e47ac54581dProduct name520200611
2e254488-9fcb-41b3-a7c3-e2c9a3941b29Product name120200603
b4ff0805-126a-406d-9cae-fc34fd8e8889Product name120190711
98e65af1-f5d0-75d5-c930-f8a4ce4c3284Product name920190211
e4d463bc-c674-43cb-be06-82786f310d01Product name120150326
0916dcfb-331f-89b1-8eac-6f7dc76d82daProduct name120140508
d7fc3d53-5a6c-de82-2808-1780f175f17eProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82009-051-05Bupropion HydrochlorideXL500 in 1 BOTTLETABLET, EXTENDED RELEASE5006

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
82009-051-05EA - Each82009-05182e48176-5a35-48df-92b5-8243ebaa471e12023-09-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82009-051BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [QUALLENT PHARMACEUTICALS HEALTH LLC]2Current NDC, 1 package rows20241017_56df4e22-81ca-48a4-a8e2-038448417355.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
993541buPROPion HCl 150 MG 24HR Extended Release Oral TabletPSN56df4e22-81ca-48a4-a8e2-0384484173556
993557buPROPion HCl 300 MG 24HR Extended Release Oral TabletPSN56df4e22-81ca-48a4-a8e2-0384484173556
99354124 HR bupropion hydrochloride 150 MG Extended Release Oral TabletSCD56df4e22-81ca-48a4-a8e2-0384484173556
99355724 HR bupropion hydrochloride 300 MG Extended Release Oral TabletSCD56df4e22-81ca-48a4-a8e2-0384484173556
993541bupropion HCl XL 150 MG 24 HR Extended Release Oral TabletSY56df4e22-81ca-48a4-a8e2-0384484173556
993557bupropion HCl XL 300 MG 24 HR Extended Release Oral TabletSY56df4e22-81ca-48a4-a8e2-0384484173556

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
82009-051-0582009005105500 TABLET, EXTENDED RELEASE in 1 BOTTLE (82009-051-05) 2023-07-07NoNoHistorical